Published On: Wed, Oct 19th, 2016

Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) Latest Broker Views


A number of investment brokers have recently updated their price targets on shares of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX).

Most recent broker ratings

10/06/2016 – UBS began new coverage on Allscripts Healthcare Solutions, Inc. giving the company a “buy” rating. They now have a USD 17 price target on the stock.

09/22/2016 – Allscripts Healthcare Solutions, Inc. had its “outperform” rating reiterated by analysts at Leerink Swann. They now have a USD 17 price target on the stock.

08/05/2016 – Allscripts Healthcare Solutions, Inc. had its “neutral” rating reiterated by analysts at Piper Jaffray. They now have a USD 15 price target on the stock.

05/13/2016 – Allscripts Healthcare Solutions, Inc. had its “neutral” rating reiterated by analysts at Citigroup. They now have a USD 14 price target on the stock.

03/30/2016 – Allscripts Healthcare Solutions, Inc. was upgraded to “overweight” by analysts at Morgan Stanley. They now have a USD 16 price target on the stock.

03/23/2016 – Allscripts Healthcare Solutions, Inc. had its “market perform” rating reiterated by analysts at FBR Capital Markets.

02/19/2016 – Allscripts Healthcare Solutions, Inc. had its “neutral” rating reiterated by analysts at Goldman Sachs. They now have a USD 13 price target on the stock.

02/19/2016 – Allscripts Healthcare Solutions, Inc. had its “buy” rating reiterated by analysts at Deutsche Bank. They now have a USD 15 price target on the stock.

02/19/2016 – Allscripts Healthcare Solutions, Inc. had its “outperform” rating reiterated by analysts at Cowen. They now have a USD 16 price target on the stock.

02/19/2016 – Allscripts Healthcare Solutions, Inc. had its “equal weight” rating reiterated by analysts at Barclays. They now have a USD 14 price target on the stock.

02/19/2016 – Allscripts Healthcare Solutions, Inc. had its “outperform” rating reiterated by analysts at RBC Capital. They now have a USD 17 price target on the stock.

01/22/2016 – Allscripts Healthcare Solutions, Inc. had its “buy” rating reiterated by analysts at Argus. They now have a USD 19 price target on the stock.

01/05/2016 – Allscripts Healthcare Solutions, Inc. had its “hold” rating reiterated by analysts at Topeka Capital Markets. They now have a USD 15 price target on the stock.

01/04/2016 – Allscripts Healthcare Solutions, Inc. was downgraded to “market perform” by analysts at Raymond James.

12/02/2015 – Allscripts Healthcare Solutions, Inc. had its “buy” rating reiterated by analysts at Canaccord Genuity.

The share price of Allscripts Healthcare Solutions, Inc. (NASDAQ:MDRX) was up +1.77% during the last day of trading, with a day high of 13.25. 1393005 shares were traded during the last session.

The stock’s 50 day moving average is 13.02 and its 200 day moving average is 13.29. The stock’s market capitalization is 2.47B. Allscripts Healthcare Solutions, Inc. has a 52-week low of 11.47 and a 52-week high of 15.78.

Allscripts Healthcare Solutions, Inc. delivers information technology (IT) and services to help healthcare organizations in clinical, financial and operational results. The Company operates through two segments: Clinical and Financial Solutions, and Population Health. The Clinical and Financial Solutions segment includes the sale of integrated clinical software applications and financial and information solutions, which primarily include electronic health record (EHR)-related software, financial and practice management software, related installation, support and maintenance, outsourcing, hosting, revenue cycle management, training and electronic claims administration services. Its Population Health segment includes sale of health management and coordinated care solutions that are focused on hospitals, health systems, other care facilities and accountable care organizations. These solutions enable clients to connect, transition, analyze, and coordinate care across the care community.